BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23917801)

  • 1. Ambivalence and its influence on participation in screening for colorectal cancer.
    Oster C; Zajac I; Flight I; Hart E; Young GP; Wilson C; Turnbull D
    Qual Health Res; 2013 Sep; 23(9):1188-201. PubMed ID: 23917801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician-patient colorectal cancer screening discussions by physicians' screening rates.
    O'Farrell CM; Green BB; Reid RJ; Bowen D; Baldwin LM
    J Am Board Fam Med; 2012; 25(6):771-81. PubMed ID: 23136315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploratory study examining barriers to participation in colorectal cancer screening.
    Paddison JS; Yip MJ
    Aust J Rural Health; 2010 Feb; 18(1):11-5. PubMed ID: 20136809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer screening in first-degree relatives of colorectal cancer: participation, knowledge, and barriers against screening.
    Gimeno García AZ; Quintero E; Nicolás Pérez D; Hernández M; JiménezSosa A
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1165-71. PubMed ID: 21989122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys.
    Wong MC; John GK; Hirai HW; Lam TY; Luk AK; Ching JY; Ng SS; Chan FK; Griffiths SM; Sung JJ
    Cancer Causes Control; 2012 Sep; 23(9):1541-8. PubMed ID: 22836914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing colorectal cancer screening in rural southern Taiwan.
    Lin YH; Kao CC
    Cancer Nurs; 2013; 36(4):284-91. PubMed ID: 22964866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equity of colorectal cancer screening: which groups have inequitable participation and what can we do about it?
    Ward PR; Javanparast S; Wilson C
    Aust J Prim Health; 2011; 17(4):334-46. PubMed ID: 22112702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To participate or not? Giving voice to gender and socio-economic differences in colorectal cancer screening programmes.
    Molina-Barceló A; Salas Trejo D; Peiró-Pérez R; Málaga López A
    Eur J Cancer Care (Engl); 2011 Sep; 20(5):669-78. PubMed ID: 21771129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of communicating social comparison information on risk perceptions for colorectal cancer.
    Lipkus IM; Klein WM
    J Health Commun; 2006 Jun; 11(4):391-407. PubMed ID: 16720537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician counseling for colorectal cancer screening: impact on patient attitudes, beliefs, and behavior.
    Fenton JJ; Jerant AF; von Friederichs-Fitzwater MM; Tancredi DJ; Franks P
    J Am Board Fam Med; 2011; 24(6):673-81. PubMed ID: 22086810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trust, choice and obligation: a qualitative study of enablers of colorectal cancer screening in South Australia.
    Ward PR; Coffey C; Meyer S
    Sociol Health Illn; 2015 Sep; 37(7):988-1006. PubMed ID: 25912247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Fault-line of an earthquake": a qualitative examination of barriers and facilitators to colorectal cancer screening in rural, Eastern North Carolina.
    Jilcott Pitts SB; Lea CS; May CL; Stowe C; Hamill DJ; Walker KT; Fitzgerald TL
    J Rural Health; 2013; 29(1):78-87. PubMed ID: 23289658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study.
    Toft EL; Kaae SE; Malmqvist J; Brodersen J
    Scand J Prim Health Care; 2019 Jun; 37(2):145-154. PubMed ID: 31079520
    [No Abstract]   [Full Text] [Related]  

  • 15. Manipulating perceptions of colorectal cancer threat: implications for screening intentions and behaviors.
    Lipkus IM; Green LG; Marcus A
    J Health Commun; 2003; 8(3):213-28. PubMed ID: 12857652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic, social cognitive and social ecological predictors of intention and participation in screening for colorectal cancer.
    Gregory TA; Wilson C; Duncan A; Turnbull D; Cole SR; Young G
    BMC Public Health; 2011 Jan; 11():38. PubMed ID: 21232156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for colorectal cancer: sense and sensibilities.
    Van Hal G; Hoeck S; Van Roosbroeck S
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S156-63. PubMed ID: 21943969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge, perception and practices of colorectal cancer screening in an ethnically diverse population.
    Koo JH; Arasaratnam MM; Liu K; Redmond DM; Connor SJ; Sung JJ; Leong RW
    Cancer Epidemiol; 2010 Oct; 34(5):604-10. PubMed ID: 20580631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willingness to take a screening test for colorectal cancer: a community-based survey in Malaysia.
    Naing C; Jun YK; Yee WM; Waqiyuddin SJ; Lui LC; Shaung OY; Haw FJ
    Eur J Cancer Prev; 2014 Mar; 23(2):71-5. PubMed ID: 23722440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Most participate in faecal immunochemical test-based colorectal cancer screening out of curiosity about their chances of developing cancer.
    Denters MJ; Bossuyt PM; Deutekom M; Fockens P; Dekker E
    Eur J Cancer Prev; 2015 May; 24(3):176-9. PubMed ID: 25734239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.